Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment

Soluble immune checkpoint molecules are emerging novel mediators of immune regulation. However, it is unclear whether soluble immune checkpoint proteins affect the development of hepatocellular carcinoma (HCC) during nucleos(t)ide analogue (NA) treatment in patients with chronic hepatitis B virus in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozuka, Ritsuzo, Enomoto, Masaru, Dong, Minh Phuong, Hai, Hoang, Thuy, Le Thi Thanh, Odagiri, Naoshi, Yoshida, Kanako, Kotani, Kohei, Motoyama, Hiroyuki, Kawamura, Etsushi, Hagihara, Atsushi, Fujii, Hideki, Uchida-Kobayashi, Sawako, Tamori, Akihiro, Kawada, Norifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741806/
https://www.ncbi.nlm.nih.gov/pubmed/34996935
http://dx.doi.org/10.1038/s41598-021-03706-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741806/
https://www.ncbi.nlm.nih.gov/pubmed/34996935
http://dx.doi.org/10.1038/s41598-021-03706-w

Ejemplares similares